Skip to main content
PMC home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1999;8(6):313–318. doi: 10.1080/09629359990324

Killer-cell inhibitory receptors, CD158a/b, are upregulated by interleukin-2, but not interferon-gamma or interleukin-4.

T Kogure 1, H Fujinaga 1, A Niizawa 1, L X Hai 1, Y Shimada 1, H Ochiai 1, K Terasawa 1
PMCID: PMC1781812  PMID: 10815620

Abstract

Although it is now accepted that killer-cell inhibitory receptors (KIRs), which were molecularly cloned in 1995, deliver negative signals to natural killer (NK) cells regarding the recognition of target cells, it is still unclear how the expression of these receptors on lymphocytes is regulated. Therefore, we investigated the regulation of expression of representative KIRs, CD158a and CD158b, by cytokines such as interleukin-2 (IL-2), IL-4 and interferon-gamma (IFN-gamma). Neither IL-4 nor IFN-gamma affected the expression of CD158a/b, but incubation for 48 h with IL-2, which enhances the killer activity of NK cells, upregulated the expression of the KIRs. This upregulation by IL-2 was also observed in CD16-positive cells sorted from total lymphocytes. In contrast, IL-4, which is a down-regulator of IL-2-induced killer responses, did not change the level of CD158a/b expression when added after the IL-2 treatment. These findings suggest that IL-2 plays an important role in the regulation of CD158a/b expression, and might be involved in controlling NK activity via regulating expression of these molecules.

Full Text

The Full Text of this article is available as a PDF (214.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Binstadt B. A., Brumbaugh K. M., Dick C. J., Scharenberg A. M., Williams B. L., Colonna M., Lanier L. L., Kinet J. P., Abraham R. T., Leibson P. J. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity. 1996 Dec;5(6):629–638. doi: 10.1016/s1074-7613(00)80276-9. [DOI] [PubMed] [Google Scholar]
  2. Brooks B., Chapman K., Lawry J., Meager A., Rees R. C. Suppression of lymphokine-activated killer (LAK) cell induction mediated by interleukin-4 and transforming growth factor-beta 1: effect of addition of exogenous tumour necrosis factor-alpha and interferon-gamma, and measurement of their endogenous production. Clin Exp Immunol. 1990 Dec;82(3):583–589. doi: 10.1111/j.1365-2249.1990.tb05494.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ciccone E., Pende D., Viale O., Than A., Di Donato C., Orengo A. M., Biassoni R., Verdiani S., Amoroso A., Moretta A. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J Exp Med. 1992 Oct 1;176(4):963–971. doi: 10.1084/jem.176.4.963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Colonna M., Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science. 1995 Apr 21;268(5209):405–408. doi: 10.1126/science.7716543. [DOI] [PubMed] [Google Scholar]
  5. Colonna M. Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors. Immunol Rev. 1997 Feb;155:127–133. doi: 10.1111/j.1600-065x.1997.tb00945.x. [DOI] [PubMed] [Google Scholar]
  6. D'Andrea A., Chang C., Franz-Bacon K., McClanahan T., Phillips J. H., Lanier L. L. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. J Immunol. 1995 Sep 1;155(5):2306–2310. [PubMed] [Google Scholar]
  7. Daëron M. Fc receptor biology. Annu Rev Immunol. 1997;15:203–234. doi: 10.1146/annurev.immunol.15.1.203. [DOI] [PubMed] [Google Scholar]
  8. Frohn C., Schlenke P., Kirchner H. The repertoire of HLA-Cw-specific NK cell receptors CD158 a/b (EB6 and GL183) in individuals with different HLA phenotypes. Immunology. 1997 Dec;92(4):567–570. doi: 10.1046/j.1365-2567.1997.00374.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gardiner C. M., Reen D. J. Differential cytokine regulation of natural killer cell-mediated necrotic and apoptotic cytotoxicity. Immunology. 1998 Apr;93(4):511–517. doi: 10.1046/j.1365-2567.1998.00464.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Grimm E. A., Robb R. J., Roth J. A., Neckers L. M., Lachman L. B., Wilson D. J., Rosenberg S. A. Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. J Exp Med. 1983 Oct 1;158(4):1356–1361. doi: 10.1084/jem.158.4.1356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Handgretinger R., Kimmig A., Lang P., Daurer B., Kuci S., Bruchelt G., Treuner J., Niethammer D. Interferon-gamma upregulates the susceptibility of human neuroblastoma cells to interleukin-2-activated natural killer cells. Nat Immun Cell Growth Regul. 1989;8(4):189–196. [PubMed] [Google Scholar]
  12. Lanier L. L., Phillips J. H. Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today. 1996 Feb;17(2):86–91. doi: 10.1016/0167-5699(96)80585-8. [DOI] [PubMed] [Google Scholar]
  13. Ljunggren H. G., Kärre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today. 1990 Jul;11(7):237–244. doi: 10.1016/0167-5699(90)90097-s. [DOI] [PubMed] [Google Scholar]
  14. Moretta A., Biassoni R., Bottino C., Pende D., Vitale M., Poggi A., Mingari M. C., Moretta L. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev. 1997 Feb;155:105–117. doi: 10.1111/j.1600-065x.1997.tb00943.x. [DOI] [PubMed] [Google Scholar]
  15. Moretta A., Bottino C., Pende D., Tripodi G., Tambussi G., Viale O., Orengo A., Barbaresi M., Merli A., Ciccone E. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med. 1990 Dec 1;172(6):1589–1598. doi: 10.1084/jem.172.6.1589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Moretta A., Tambussi G., Bottino C., Tripodi G., Merli A., Ciccone E., Pantaleo G., Moretta L. A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function. J Exp Med. 1990 Mar 1;171(3):695–714. doi: 10.1084/jem.171.3.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Moretta L., Ciccone E., Moretta A., Höglund P., Ohlén C., Kärre K. Allorecognition by NK cells: nonself or no self? Immunol Today. 1992 Aug;13(8):300–306. doi: 10.1016/0167-5699(92)90042-6. [DOI] [PubMed] [Google Scholar]
  18. Nagler A., Lanier L. L., Phillips J. H. The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation. J Immunol. 1988 Oct 1;141(7):2349–2351. [PubMed] [Google Scholar]
  19. Pflueger E., Mueller E. A., Anderer F. A. Preservation of cytotoxic function during multi-cycle immunomagnetic cell separations of human NK cells using a new type of magnetic bead. J Immunol Methods. 1990 May 25;129(2):165–173. doi: 10.1016/0022-1759(90)90436-y. [DOI] [PubMed] [Google Scholar]
  20. Psarommatis I. M., Tsakanikos M. D., Kontorgianni A. D., Ntouniadakis D. E., Apostolopoulos N. K. Profound hearing loss and presence of click-evoked otoacoustic emissions in the neonate: a report of two cases. Int J Pediatr Otorhinolaryngol. 1997 Apr 11;39(3):237–243. doi: 10.1016/s0165-5876(97)01491-2. [DOI] [PubMed] [Google Scholar]
  21. Raulet D. H., Held W. Natural killer cell receptors: the offs and ons of NK cell recognition. Cell. 1995 Sep 8;82(5):697–700. doi: 10.1016/0092-8674(95)90466-2. [DOI] [PubMed] [Google Scholar]
  22. Robertson M. J., Manley T. J., Donahue C., Levine H., Ritz J. Costimulatory signals are required for optimal proliferation of human natural killer cells. J Immunol. 1993 Mar 1;150(5):1705–1714. [PubMed] [Google Scholar]
  23. Sayers T. J., Mason A. T., Ortaldo J. R. Regulation of human natural killer cell activity by interferon-gamma: lack of a role in interleukin 2-mediated augmentation. J Immunol. 1986 Mar 15;136(6):2176–2180. [PubMed] [Google Scholar]
  24. Smith K. A. Interleukin-2: inception, impact, and implications. Science. 1988 May 27;240(4856):1169–1176. doi: 10.1126/science.3131876. [DOI] [PubMed] [Google Scholar]
  25. Storkus W. J., Alexander J., Payne J. A., Cresswell P., Dawson J. R. The alpha 1/alpha 2 domains of class I HLA molecules confer resistance to natural killing. J Immunol. 1989 Dec 1;143(11):3853–3857. [PubMed] [Google Scholar]
  26. Trinchieri G. Biology of natural killer cells. Adv Immunol. 1989;47:187–376. doi: 10.1016/S0065-2776(08)60664-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Vivier E., Daëron M. Immunoreceptor tyrosine-based inhibition motifs. Immunol Today. 1997 Jun;18(6):286–291. doi: 10.1016/s0167-5699(97)80025-4. [DOI] [PubMed] [Google Scholar]
  28. Wagtmann N., Biassoni R., Cantoni C., Verdiani S., Malnati M. S., Vitale M., Bottino C., Moretta L., Moretta A., Long E. O. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity. 1995 May;2(5):439–449. doi: 10.1016/1074-7613(95)90025-x. [DOI] [PubMed] [Google Scholar]
  29. Yokoyama W. M., Seaman W. E. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol. 1993;11:613–635. doi: 10.1146/annurev.iy.11.040193.003145. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES